“We use cookies on this website to enhance your user experience and to personalise content. By clicking any link or continuing to use our Website you agree to our cookies as per our Privacy Policy. Read More” Ok, I agree

Vancomycin Hydrochloride (Vancomycin Hydrochloride)

Trade Name : VANCOMYCIN HYDROCHLORIDE

Baxter Healthcare Corporation

INJECTION, SOLUTION

Strength 500 mg/100mL

Storage and handling for VANCOMYCIN HYDROCHLORIDE

VANCOMYCIN HYDROCHLORIDE Glycopeptide Antibacterial [EPC],Glycopeptides [CS]

Disclaimer

GNH India is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Vancomycin Hydrochloride (Vancomycin Hydrochloride) which is also known as VANCOMYCIN HYDROCHLORIDE and Manufactured by Baxter Healthcare Corporation. It is available in strength of 500 mg/100mL per ml. Read more

Vancomycin Hydrochloride (Vancomycin Hydrochloride) is supplied for Tenders/ Emergency imports/ Un - licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials.  Click to know price.     Read less

Delivery Process

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

We’ll Get in Touch

Once we review your request, we’ll send you an estimated price for the medicine within 2-5 days.

Confirmation and Payment

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Submit a Request

You can fill in a request for your medicine through the form provided. You can access the form by clicking on the ‘Get Price’ button.

Product information is meant for

Wholesalers Suppliers Exporters Doctors MOH Tender Supplies Hospitals Brand CROs Comparator Supplies Generic Cooperate Sourcing Individual Patients Indian Institutional Buyers

Packaging and Delivery

Validated Cold Chain Shipment

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more

About GNH

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

We deliver your medicines through a validated cold chain shipment process. This process is used as these medicines need to manufactured, transported and stored at very specific temperatures, utilizing thermal and refrigerated packaging methods.

Read more
  • No data
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin and other antibacterial drugs, vancomycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
  • Vancomycin Injection, USP in the GALAXY plastic container (PL 2040) contains vancomycin, added as Vancomycin Hydrochloride, USP. It is a tricyclic glycopeptide antibiotic drug derived from (formerly ). The molecular formula is CHClNOu2022 HCl and the molecular weight is 1,485.71. Vancomycin hydrochloride has the following structural formula:
  • Vancomycin Injection, USP in the GALAXY plastic container (PL 2040) is a frozen, iso-osmotic, sterile, nonpyrogenic premixed 100 mL, 150 mL, or 200 mL solution containing 500 mg, 750 mg, or 1 g Vancomycin respectively as Vancomycin hydrochloride. Each 100 mL of solution contains approximately 5 g of Dextrose Hydrous, USP or 0.9 g of Sodium Chloride, USP. The pH of the solution may have been adjusted with hydrochloric acid and/or sodium hydroxide. Thawed solutions have a pH in the range of 3.0 to 5.0. After thawing to room temperature, this solution is intended for intravenous use only.
  • This GALAXY container is fabricated from a specially designed multilayer plastic (PL 2040). Solutions are in contact with the polyethylene layer of this container and can leach out certain chemical components of the plastic in very small amounts within the expiration period. The suitability of the plastic has been confirmed in tests in animals according to USP biological tests for plastic containers as well as by tissue culture toxicity studies.
  • In subjects with normal kidney function, multiple intravenous dosing of 1 g of vancomycin (15 mg/kg) infused over 60 minutes produces mean plasma concentrations of approximately 63 mcg/mL immediately after the completion of infusion, mean plasma concentrations of approximately 23 mcg/mL 2 hours after infusion, and mean plasma concentrations of approximately 8 mcg/mL 11 hours after the end of the infusion. Multiple dosing of 500 mg infused over 30 minutes produces mean plasma concentrations of about 49 mcg/mL at the completion of infusion, mean plasma concentrations of about 19 mcg/mL 2 hours after infusion, and mean plasma concentrations of about 10 mcg/mL 6 hours after infusion. The plasma concentrations during multiple dosing are similar to those after a single dose.
  • The mean elimination half-life of vancomycin from plasma is 4 to 6 hours in subjects with normal renal function. In the first 24 hours, about 75% of an administered dose of vancomycin is excreted in urine by glomerular filtration. Mean plasma clearance is about 0.058 L/kg/h, and mean renal clearance is about 0.048 L/kg/h. Renal dysfunction slows excretion of vancomycin. In anephric patients, the average half-life of elimination is 7.5 days. The distribution coefficient is from 0.3 to 0.43 L/kg. There is no apparent metabolism of the drug. About 60% of an intraperitoneal dose of vancomycin administered during peritoneal dialysis is absorbed systemically in 6 hours. Serum concentrations of about 10 mcg/mL are achieved by intraperitoneal injection of 30 mg/kg of vancomycin. However, the safety and efficacy of the intraperitoneal use of vancomycin has not been established in adequate and well-controlled trials (see ).
  • Total systemic and renal clearance of vancomycin may be reduced in the elderly.
  • Vancomycin is approximately 55% serum protein bound as measured by ultrafiltration at vancomycin serum concentrations of 10 to 100 mcg/mL. After IV administration of vancomycin, inhibitory concentrations are present in pleural, pericardial, ascitic, and synovial fluids; in urine; in peritoneal dialysis fluid; and in atrial appendage tissue. Vancomycin does not readily diffuse across normal meninges into the spinal fluid; but, when the meninges are inflamed, penetration into the spinal fluid occurs.
  • Vancomycin is indicated for the treatment of serious or severe infections caused by susceptible strains of methicillin-resistant (beta-lactam-resistant) staphylococci. It is indicated for penicillin-allergic patients, for patients who cannot receive or who have failed to respond to other drugs, including the penicillins or cephalosporins, and for infections caused by vancomycin-susceptible organisms that are resistant to other antimicrobial drugs. Vancomycin is indicated for initial therapy when methicillin-resistant staphylococci are suspected, but after susceptibility data are available, therapy should be adjusted accordingly.
  • Vancomycin is effective in the treatment of staphylococcal endocarditis. Its effectiveness has been documented in other infections due to staphylococci, including septicemia, bone infections, lower respiratory tract infections, skin and skin structure infections. When staphylococcal infections are localized and purulent, antibiotics are used as adjuncts to appropriate surgical measures.
  • Vancomycin has been reported to be effective alone or in combination with an aminoglycoside for endocarditis caused by or . For endocarditis caused by enterococci (), vancomycin has been reported to be effective only in combination with an aminoglycoside.
  • Vancomycin has been reported to be effective for the treatment of diphtheroid endocarditis. Vancomycin has been used successfully in combination with either rifampin, an aminoglycoside, or both in early-onset prosthetic valve endocarditis caused by or diphtheroids.
  • Specimens for bacteriologic cultures should be obtained in order to isolate and identify causative organisms and to determine their susceptibilities to vancomycin.
  • To reduce the development of drug-resistant bacteria and maintain the effectiveness of vancomycin and other antibacterial drugs, vancomycin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
  • Vancomycin is contraindicated in patients with known hypersensitivity to this antibiotic. Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.
  • No data
  • Prolonged use of vancomycin may result in the overgrowth of nonsusceptible microorganisms. Careful observation of the patient is essential. If superinfection occurs during therapy, appropriate measures should be taken. In rare instances, there have been reports of pseudomembranous colitis due to developing in patients who received intravenous vancomycin.
  • Risk of High Sodium Load:
  • Each 100mL solution of Vancomycin Injection, USP contains 0.9 g of Sodium Chloride, USP. Avoid use of Vancomycin Injection, USP with Sodium Chloride, USP in patients with congestive heart failure, elderly patients and patients requiring restricted sodium intake.
  • Serial tests of auditory function may be helpful in order to minimize the risk of ototoxicity.
  • Reversible neutropenia has been reported in patients receiving vancomycin (see ). Patients who will undergo prolonged therapy with vancomycin or those who are receiving concomitant drugs that may cause neutropenia should have periodic monitoring of the leukocyte count.
  • Vancomycin is irritating to tissue and must be given by a secure intravenous route of administration. Pain, tenderness, and necrosis occur with inadvertent extravasation. Thrombophlebitis may occur, the frequency and severity of which can be minimized by slow infusion of the drug and by rotation of venous access sites.
  • There have been reports that the frequency of infusion-related events (including hypotension, flushing, erythema, urticaria, and pruritus) increases with the concomitant administration of anesthetic agents. Infusion-related events may be minimized by the administration of vancomycin as a 60-minute infusion prior to anesthetic induction. The safety and efficacy of vancomycin administered by the intrathecal (intralumbar or intraventricular) route or by the intraperitoneal route have not been established by adequate and well-controlled trials.
  • Reports have revealed that administration of sterile vancomycin by the intraperitoneal route during continuous ambulatory peritoneal dialysis (CAPD) has resulted in a syndrome of chemical peritonitis. To date, this syndrome has ranged from a cloudy dialysate alone to a cloudy dialysate accompanied by variable degrees of abdominal pain and fever. This syndrome appears to be short-lived after discontinuation of intraperitoneal vancomycin.
  • Prescribing vancomycin in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.
  • No data
  • Supportive care is advised, with maintenance of glomerular filtration. Vancomycin is poorly removed by dialysis.
  • Hemofiltration and hemoperfusion with polysulfone resin have been reported to result in increased vancomycin clearance. The median lethal intravenous dose is 319 mg/kg in rats and 400 mg/kg in mice.
  • To obtain up-to-date information about the treatment of overdose, a good resource is your certified Regional Poison Control Center. Telephone numbers of certified poison control centers are listed in the . In managing overdosage, consider the possibility of multiple drug overdoses, interaction among drugs, and unusual drug kinetics in your patient.
  • Vancomycin Injection, USP in the GALAXY plastic container (PL 2040) is intended for intravenous use only.
  • Vancomycin in the GALAXY Container (PL 2040 Plastic) is to be administered orally
  • Vancomycin Injection, USP is supplied as a frozen, iso-osmotic, premixed solution in a 100 mL, 150 mL, or 200 mL single dose GALAXY plastic container (PL 2040) in the following vancomycin doses:
  • Store at or below -20u00b0C (-4u00b0F).
  • See DIRECTIONS FOR USE OF Vancomycin Injection, USP in GALAXY plastic container (PL 2040).
  • The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature (25u00b0C/77u00b0F) or for 30 days when stored under refrigeration (5u00b0C/41u00b0F). Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • In animal studies, hypotension and bradycardia occurred in dogs receiving an intravenous infusion of vancomycin 25 mg/kg, at a concentration of 25 mg/mL and an infusion rate of 13.3 mL/min.
  • No data
  • Baxter Healthcare Corporation
  • Baxter and Galaxy are registered trademarks of Baxter International Inc.
  • 07-19-00-489
  • Revised: October 2018
  • Container Label
  • NDC 0338-3551-48
  • Vancomycin Injection, USPin 5% Dextrose
  • 500 mg per 100 mLn
  • GALAXY Single-Dose Container Discard unused portion
  • Code 2G3551Sterile Nonpyrogenic Iso-osmotic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to500 mg vancomycin with approx. 5 g Dextrose Hydrous, USP in Water forInjection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.
  • Cautions: Do not add supplementary medication or additives.
  • Rx Onlyn- Do not force thaw. n- Do not refreeze
  • PL 2040 Plastic
  • Arrayn- Baxter
  • Baxter and Galaxy are trademarks of Baxter International Inc.n , Deerfield, IL 60015 USA
  • 07-34-74-761
  • Carton Labels
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-74-764
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-74-764
  • Vancomycin Injection, USP in 5% Dextrose 500 mg per 100 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3551-48Code 2G3551
  • *FOR BAR CODE POSITION ONLY(01) 20303383551485
  • Vancomycin Injection, USP in 5% Dextrose 500 mg per 100 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3551-48Code 2G3551
  • *FOR BAR CODE POSITION ONLY(01) 20303383551485
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 5 g Dextrose Hydrous, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 5 g Dextrose Hydrous, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • CODE: 2G3551LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X(21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX
  • CODE: 2G3551LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X (21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX07-06-77-861
  • NDC 0338-3552-48
  • Vancomycin Injection, USP in 5% Dextrose
  • 1 g per 200 mLn
  • GALAXY Single-Dose Container Discard unused portion
  • Code 2G3552Sterile Nonpyrogenic Iso-osmotic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 5 g Dextrose Hydrous, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.
  • Cautions: Do not add supplementary medication or additives.
  • Rx Onlyn- Do not force thaw. n- Do not refreeze
  • PL 2040 Plastic
  • Arrayn- Baxter
  • Baxter and Galaxy are trademarks of Baxter International Inc.n , Deerfield, IL 60015 USA
  • 07-34-74-763
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-74-766
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-74-766
  • Vancomycin Injection, USP in 5% Dextrose 1 g per 200 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3552-48Code 2G3552
  • *FOR BAR CODE POSITION ONLY(01) 20303383552482
  • Vancomycin Injection, USP in 5% Dextrose 1 g per 200 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3552-48Code 2G3552
  • *FOR BAR CODE POSITION ONLY(01) 20303383552482
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 5 g Dextrose Hydrous, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 5 g Dextrose Hydrous, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • CODE: 2G3552LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X(21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX
  • CODE: 2G3552LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X (21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX07-06-77-864
  • Container Label
  • NDC 0338-3580-48
  • Vancomycin Injection, USPin 5% Dextrose
  • 750 mg per 150 mLn
  • GALAXYn
  • Code 2G3580Sterile NonpyrogenicIso-osmotic
  • Each 100 mL contains: Vancomycin Hydrochloride, USPequivalent to 500 mg vancomycin with approx. 5 g DextroseHydrous, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.
  • Cautions: Do not add supplementary medication or additives.
  • Rx Onlyn- Do not force thaw. n- Do not refreeze
  • PL 2040 Plastic
  • Arrayn- Baxter
  • Baxter and Galaxy are trademarks of Baxter International Inc.n , Deerfield, IL 60015 USA
  • 07-34-74-762
  • Carton Labels
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-74-765
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-74-765
  • Vancomycin Injection, USP in 5% Dextrose 750 mg per 150 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3580-48Code 2G3580
  • *FOR BAR CODE POSITION ONLY(01) 20303383580485
  • Vancomycin Injection, USP in 5% Dextrose 750 mg per 150 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3580-48Code 2G3580
  • *FOR BAR CODE POSITION ONLY(01) 20303383580485
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 5 g Dextrose Hydrous, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 5 g Dextrose Hydrous, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • CODE: 2G3580LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X(21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX
  • CODE: 2G3580LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X (21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX07-06-77-862
  • Array
  • NDC 0338-3581-01
  • Vancomycin Injection, USPin 0.9% Sodium Chloride
  • 500 mg per 100 mLn
  • GALAXYn
  • Code 2G3590Sterile NonpyrogenicIso-osmotic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 0.9 g Sodium Chloride, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.
  • Cautions: Do not add supplementary medication or additives.
  • Rx Onlyn- Do not force thaw. n- Do not refreeze
  • PL 2040 Plastic
  • Arrayn- Baxter
  • Baxter and Galaxy are trademarks of Baxter International Inc.n , Deerfield, IL 60015 USA
  • 07-34-74-548
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-77-715
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-77-715
  • Vancomycin Injection, USP in 0.9% Sodium Chloride 500 mg per 100 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3581-01Code 2G3590
  • *FOR BAR CODE POSITION ONLY(01) 20303383581017
  • Vancomycin Injection, USP in 0.9% Sodium Chloride 500 mg per 100 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3581-01Code 2G3590
  • *FOR BAR CODE POSITION ONLY(01) 20303383581017
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 0.9 Sodium Chloride, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 0.9 Sodium Chloride, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • CODE: 2G3590LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X(21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX
  • CODE: 2G3590LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X (21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX07-06-77-865
  • Container Label
  • NDC 0338-3582-01
  • Vancomycin Injection, USPin 0.9% Sodium Chloride
  • 750 mg per 150 mLn
  • GALAXYn
  • Code 2G3591Sterile NonpyrogenicIso-osmotic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 0.9 g Sodium Chloride, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.
  • Cautions: Do not add supplementary medication or additives.
  • Rx Onlyn- Do not force thaw. n- Do not refreeze
  • PL 2040 Plastic
  • Arrayn- Baxter
  • Baxter and Galaxy are trademarks of Baxter International Inc.n , Deerfield, IL 60015 USA
  • 07-34-74-551
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-77-715
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-77-715
  • Vancomycin Injection, USP in 0.9 Sodium Chloride 750 mg per 150 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3582-01Code 2G3591
  • *FOR BAR CODE POSITION ONLY(01) 20303383582014
  • Vancomycin Injection, USP in 0.9 Sodium Chloride 750 mg per 150 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3582-01Code 2G3591
  • *FOR BAR CODE POSITION ONLY(01) 20303383582014
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 0.9 Sodium Chloride, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 0.9 Sodium Chloride, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • CODE: 2G3591LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X(21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX
  • CODE: 2G3591LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X (21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX07-06-77-863
  • Container Label
  • NDC 0338-3583-01
  • Vancomycin Injection, USPin 0.9% Sodium Chloride
  • 1 g per 200 mLn
  • GALAXYn
  • Code 2G3592Sterile NonpyrogenicIso-osmotic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 0.9 g Sodium Chloride, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.
  • Cautions: Do not add supplementary medication or additives.
  • Rx Onlyn- Do not force thaw. n- Do not refreeze
  • PL 2040 Plastic
  • Arrayn- Baxter
  • Baxter and Galaxy are trademarks of Baxter International Inc.n , Deerfield, IL 60015 USA
  • 07-34-74-553
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-77-717
  • Thaw at room temperature (25u00b0C/77u00b0F) or under refrigeration (5u00b0C/41u00b0F). Product should not be thawed by immersion in water baths or by microware irradiation. The thawed solution in GALAXY plastic container (PL 2040) remains chemically stable for 72 hours at room temperature or for 30 days when stored under refrigeration. n
  • Handle frozen product containers with care. Product containers may be fragile in the frozen state.
  • PL 2040 Plastic 07-04-77-717
  • Vancomycin Injection, USP in 0.9 Sodium Chloride 1 g per 200 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3583-01Code 2G3592
  • *FOR BAR CODE POSITION ONLY(01) 20303383583011
  • Vancomycin Injection, USP in 0.9 Sodium Chloride 1 g per 200 mL n- Arrayn- Iso-osmotic. Store at or below -20u00b0C/-4u00b0F.
  • Rx Only
  • NDC 0338-3583-01Code 2G3592
  • *FOR BAR CODE POSITION ONLY(01) 20303383583011
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 0.9 Sodium Chloride, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • GALAXY
  • Sterile Nonpyrogenic
  • Each 100 mL contains: Vancomycin Hydrochloride, USP equivalent to 500 mg vancomycin with approx. 0.9 Sodium Chloride, USP in Water for Injection, USP. pH may have been adjusted with hydrochloric acid and/or sodium hydroxide.
  • Dosage: For intravenous use only. See prescribing information.Cautions: Do not add supplementary medication or additives.
  • Arrayn- Baxter
  • Baxter and Galaxy are registered trademarks of Baxter International Inc. n , Deerfield, IL 60015 USA
  • CODE: 2G3592LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X(21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX
  • CODE: 2G3592LOT: XXXXXXXXXEXP: DD MMM YYQTY: QQSN: #########FOR PLACEMENT ONLY.(01) X XXXXXXX XXXXX X (21) XXXXXXXXX(17) XXXXXX(10) XXXXXXXXX07-06-77-866

Similar Products

Desogestrel And Ethinyl Estradiol (Emoquette)

Desogestrel And Ethinyl Estradiol (Emoquette)

Manufacturer: REMEDYREPACK INC.

Presentation: KIT

Strength:

Pack Size:

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Diphenoxylate Hydrochloride And Atropine Sulfate (Diphenoxylate Hydrochloride And Atropine Sulfate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET

Strength: 2.5; .025 mg/1; mg/1

Pack Size:

Fluoxetine Hydrochloride (Fluoxetine)

Fluoxetine Hydrochloride (Fluoxetine)

Manufacturer: REMEDYREPACK INC.

Presentation: CAPSULE

Strength: 40 mg/1

Pack Size:

Metoprolol Succinate (Metoprolol Succinate)

Metoprolol Succinate (Metoprolol Succinate)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, EXTENDED RELEASE

Strength: 25 mg/1

Pack Size:

Losartan Potassium (Losartan Potassium)

Losartan Potassium (Losartan Potassium)

Manufacturer: REMEDYREPACK INC.

Presentation: TABLET, FILM COATED

Strength: 25 mg/1

Pack Size:

Browse Our Services And Processes

Comparator Sourcing for Clinical Trials

Comparator Sourcing for Clinical Trials

GNH India brings over 10 years of experience in Comparator

Read More

Name Patient Supply

Name Patient Supply

Today, the exact cause for many rare diseases remains unknown

Read More

Validated Cold Chain Shipment

Validated Cold Chain Shipment

With shifting of pharma industry from synthetic molecules to biologic

Read More

Clinical Trials Supply

Clinical Trials Supply

STOP SOURCING..... START SMART SOURCING...... COME STRAIGHT TO THE SOURCE

Read More

Dossiers and Stability Studies

Dossiers and Stability Studies

STABILITY STUDIES STABILITY, BA / BE STUDIES Due to our active

Read More

Pharmaceutical Contract Manufacturing

Pharmaceutical Contract Manufacturing

GNH Provides Contract Manufacturing services for: Generic Medicines with following

Read More

Pricing

Pricing

PRICING POLICY Terms of sales are typically prepaid, unless otherwise

Read More

Disclaimer

Please see the Legal Notice for detailed terms and disclaimers. The Legal Notice governs the use of this Website and by accessing and using this Website you agree to be bound by and accept the Legal Notice.

Browse from other international pharmaceuticals

General

64036 Products

GNH India Brings to over 64036 Product SKUs from India all at 1 place with easy access and global deliveries.

US NDC

71252 Products

GNH India Brings to over 71252 Product SKUs from India all at 1 place with easy access and global deliveries.

Canadian DIN

51047 Products

GNH India Brings to over 51047 Product SKUs from India all at 1 place with easy access and global deliveries.

Swiss Drugs

150 Products

GNH India Brings to over 150 Product SKUs from India all at 1 place with easy access and global deliveries.

NZ Drugs

13298 Products

GNH Brings to over 13298 Product SKUs from India all at 1 place with easy access and global deliveries.

FAQ

Check out our delivery process

Can’t find what
you’re looking for?

Contact US
Get Price

Are you an existing customer or a vendor of GNH India? Log in here to

View your Transaction
COMPANY
SERVICES
QUICK LINKS
CONTACT US
Office / Warehouse Address:

Unit # G- 14, 15, 16, 17, Ground Floor, Prabhadevi Industrial Estate, Enterprises Industrial Premises, 408, Veer Sawarkar Road, Prabhadevi,
Mumbai 400025 India

US Office Address:

GNH Pharmaceuticals USA LLC,
Suite C - 1 # 499, 125 Remount Road,
Charlotte North Carolina 28203, U.S.A

Pharmexcil
DB
FIEO-2016
SiteLock

Copyright © 2023 GNHIndia .com. All Rights Reserved. Please read Legal Notice for further details.

Disclaimer: Product names, logos, brands and other trademarks featured or referred to are the property of their respective trademark holders.